PharmAbcine to participate in Jefferies Global Healthcare Conference and BIO International Convention

DAEJEON, South Korea, May 11, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the developme...

Related Keywords

Australia ,New York ,United States ,San Diego ,California ,Daejeon ,Taejon Gwangyoksi ,South Korea ,Australian ,Jin San Yoo ,Human Research Ethics Committee For Phase ,Linkedin ,Business Development Team ,International Convention ,Ir Pr Team ,Pharmabcine Inc ,Youtube ,Prnewswire Pharmabcine Inc ,Chief Executive Officer ,Jefferies Global Healthcare Conference ,Hyunsun Park ,Chief Operating Officer ,Chief Business Officer ,Vascular Endothelial Growth Factor Receptor ,Triple Negative Breast Cancer ,Age Related Macular Degeneration ,Diabetic Retinopathy ,Diabetic Macular Edema ,V Domain Ig Suppressor ,Myeloid Derived Suppressor Cells ,Clinical Trial Application ,Human Research Ethics Committee ,